- CA$2.45bn
- CA$2.39bn
- $1.17bn
- 82
- 96
- 50
- 89
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 978 | 532 | 900 | 1,311 | 1,170 |
Cost of Revenue | |||||
Gross Profit | 814 | 416 | 781 | 1,171 | 958 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 470 | 352 | 388 | 507 | 714 |
Operating Profit | 507 | 180 | 512 | 804 | 456 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 504 | 173 | 504 | 803 | 454 |
Provision for Income Taxes | |||||
Net Income After Taxes | 328 | 99.3 | 303 | 611 | 459 |
Net Income Before Extraordinary Items | |||||
Net Income | 328 | 99.3 | 303 | 611 | 459 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 328 | 99.3 | 303 | 611 | 459 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.3 | 0.771 | 2.54 | 6.07 | 5.19 |
Dividends per Share | |||||
Special Dividends per Share |